Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease
Chest. 2019 May;155(5):e117-e121. doi: 10.1016/j.chest.2019.01.034. ABSTRACT Patients with common variable immunodeficiency (CVID) can develop granulomatous-lymphocytic interstitial lung disease (GLILD), which is associated with increased morbidity